TGS Baltic has advised Simpact Ventures on its investment in Ligence as part of a round that also saw the participation of Coinvest Capital, the European Innovation Council, Estonian venture capital firm Lemonade Stand, the NGL business angel syndicate, and private investor Rita Sakus.
Ligence is a Lithuanian startup developing medical technologies.
According to TGS Baltic, "Simpact is the first VC investment fund in Poland based on the Impact Investing idea. This funding will drive Ligence’s expansion efforts as the company prepares for FDA clearance in early 2025, opening new opportunities to make high-quality cardiac diagnostics more accessible worldwide."
The TGS Baltic team included Partner Dalia Tamasauskaite-Ziliene, Senior Associate Paulius Dabulskis, Associates Auguste Linauskaite and Violeta Maciulyte, Junior Associate Viktorija Janciuraite, and Legal Assistants Inesa Grybova, Renaldas Paskevicius, and Meda Stankute.
TGS Baltic did not respond to our inquiry on the matter.
Editor's Note: After this article was published, Cobalt announced that it had advised the European Innovation Council fund. The firm's team included Partner Akvile Bosaite.
